Importo totale (1 articolo articoli):
Destinazione ordine:
marcel canoy (18 risultati)
Vai alla pagina principale dei risultati di ricerca
Filtri di ricerca
Tipo di articolo
- Tutti i tipi di prodotto
- Libri (18)
- Riviste e Giornali (Nessun altro risultato corrispondente a questo perfezionamento)
- Fumetti (Nessun altro risultato corrispondente a questo perfezionamento)
- Spartiti (Nessun altro risultato corrispondente a questo perfezionamento)
- Arte, Stampe e Poster (Nessun altro risultato corrispondente a questo perfezionamento)
- Fotografie (Nessun altro risultato corrispondente a questo perfezionamento)
- Mappe (Nessun altro risultato corrispondente a questo perfezionamento)
- Manoscritti e Collezionismo cartaceo (Nessun altro risultato corrispondente a questo perfezionamento)
Condizioni Maggiori informazioni
- Nuovo (12)
- Come nuovo, Ottimo o Quasi ottimo (1)
- Molto buono o Buono (4)
- Discreto o Mediocre (Nessun altro risultato corrispondente a questo perfezionamento)
- Come descritto (1)
Legatura
Ulteriori caratteristiche
- Prima ed. (Nessun altro risultato corrispondente a questo perfezionamento)
- Copia autograf. (Nessun altro risultato corrispondente a questo perfezionamento)
- Sovracoperta (Nessun altro risultato corrispondente a questo perfezionamento)
- Con foto (3)
- Non Print on Demand (18)
Lingua (2)
Spedizione gratuita
Paese del venditore
Valutazione venditore
-
EUR 3,50
Spedizione EUR 16,50
Spedito da Francia a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloSoftcover. Condizione: Bon. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Good. Ammareal gives back up to 15% of this item's net price to charity organizations.
-
De Triple A-econoom
Da: Attic Adventurer, Breda, Paesi Bassi
Valutazione del venditore 5 su 5 stelle
EUR 12,50
Spedizione EUR 14,50
Spedito da Paesi Bassi a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloSoftcover. Condizione: Very good.
-
Ouderen als oplossing over seniorisme, samenleven en solidariteit
Da: Mooney's bookstore, Den Helder, Paesi Bassi
Valutazione del venditore 4 su 5 stelle
EUR 21,38
Spedizione EUR 14,95
Spedito da Paesi Bassi a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New.
-
Ouderen als oplossing over seniorisme, samenleven en solidariteit
Da: Mooney's bookstore, Den Helder, Paesi Bassi
Valutazione del venditore 4 su 5 stelle
EUR 34,08
Spedizione EUR 14,95
Spedito da Paesi Bassi a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Very good.
-
EU Competition Law and Pharmaceuticals (New Horizons in Competition Law and Economics series)
Da: Books From California, Simi Valley, CA, U.S.A.
Valutazione del venditore 4 su 5 stelle
hardcover. Condizione: Very Good.
-
EU Competition Law and Pharmaceuticals (eng)
Da: Brook Bookstore On Demand, Napoli, NA, Italia
Valutazione del venditore 3 su 5 stelle
EUR 156,64
Spedizione EUR 6,80
Spedito da Italia a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new.
-
EU Competition Law and Pharmaceuticals
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 169,50
Spedizione EUR 5,79
Spedito da Regno Unito a U.S.A.Quantità: 15 disponibili
Aggiungi al carrelloHRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
-
EU Competition Law and Pharmaceuticals
Da: Books Puddle, New York, NY, U.S.A.
Valutazione del venditore 4 su 5 stelle
Condizione: New.
-
EU Competition Law and Pharmaceuticals
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Valutazione del venditore 5 su 5 stelle
EUR 171,15
Spedizione EUR 10,50
Spedito da Irlanda a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. 2022. Hardback. . . . . .
-
EU Competition Law and Pharmaceuticals
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, GB, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Da: Rarewaves.com USA, London, LONDO, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 194,64
Spedizione gratuita
Spedito da Regno Unito a U.S.A.Quantità: 9 disponibili
Aggiungi al carrelloHardback. Condizione: New. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels - in the context of current issues and future trends, including those related to COVID-19 - and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law.
-
EU Competition Law and Pharmaceuticals
Da: Revaluation Books, Exeter, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 182,13
Spedizione EUR 14,43
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 307 pages. 9.50x6.25x1.00 inches. In Stock.
-
EU Competition Law and Pharmaceuticals (Hardcover)
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, Cheltenham, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Valutazione del venditore 5 su 5 stelle
Hardcover. Condizione: new. Hardcover. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels in the context of current issues and future trends, including those related to COVID-19 and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
-
EU Competition Law and Pharmaceuticals
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 211,48
Spedizione EUR 14,54
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. New copy - Usually dispatched within 4 working days.
-
EU Competition Law and Pharmaceuticals
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Da: Kennys Bookstore, Olney, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 218,16
Spedizione EUR 9,01
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. 2022. Hardback. . . . . . Books ship from the US and Ireland.
-
EU Competition Law and Pharmaceuticals
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, GB, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Da: Rarewaves.com UK, London, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 184,86
Spedizione EUR 75,02
Spedito da Regno Unito a U.S.A.Quantità: 9 disponibili
Aggiungi al carrelloHardback. Condizione: New. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels - in the context of current issues and future trends, including those related to COVID-19 - and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law.
-
EU Competition Law and Pharmaceuticals (Hardcover)
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, Cheltenham, 2022
ISBN 10: 1802204407 ISBN 13: 9781802204407
Da: AussieBookSeller, Truganina, VIC, Australia
Valutazione del venditore 5 su 5 stelle
EUR 297,48
Spedizione EUR 31,73
Spedito da Australia a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control.The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels in the context of current issues and future trends, including those related to COVID-19 and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed.Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
-
EUR 15,00
Spedizione EUR 105,00
Spedito da Germania a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Gut. Zustand: Gut | Sprache: Niederländisch | Produktart: Bücher | Keine Beschreibung verfügbar.
-
EUR 15,45
Spedizione EUR 105,00
Spedito da Germania a U.S.A.Quantità: 3 disponibili
Aggiungi al carrelloCondizione: Hervorragend. Zustand: Hervorragend | Sprache: Niederländisch | Produktart: Bücher | Keine Beschreibung verfügbar.
